Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 27, 2025
Introduction
Following
the
approval
of
Chimeric
Antigen
Receptor
T-cell
Immunotherapy(CAR-T)
in
multiple
countries,
Food
and
Drug
Administration
(FDA)
approved
tumor-infiltrating
lymphocytes
(TILs)
receptor-engineered
T
cells
(TCR-T)
treatments
this
year.
The
utilization
adoptive
immunotherapy
tumor
treatment
has
become
increasingly
prominent.
Optimizing
cytotoxic
effects
immune
under
vitro
culture
conditions
represents
a
current
hot
research
topic
domain.
Methods
In
experiment,
we
conducted
heat
on
Jurkat-derived
at
39°C.
On
basis,
utilized
nine
distinct
injectable
solutions
over
70
monomer
components
Traditional
Chinese
Medicine
(TCM).
Subsequently,
co-cultured
these
treated
Jurkat
with
K562-eGFP
cells,
co-culture
process
was
monitored
real-time
using
IncuCyte
live-cell
analysis
system.
Equally
important,
combined
HiMAP
high-throughput
transcriptome
sequencing,
proteomics,
metabolomics
for
in-depth
examination.
We
screened
compounds
possessing
anti-tumor
properties
thoroughly
investigated
their
mechanisms
action.
Results
Discussion
findings
indicated
that
heating
augmented
effect
against
malignant
tumors,
optimal
achieved
when
were
exposed
to
39°C
duration
24
hours(48%
increase
cell
proliferation
rate
compared
37°C
treatment).
By
triggering
generation
shock
proteins
facilitating
mitochondrial
energy
supply,
amplified
functions
cells.
analyzing
data,
identified
3
more
than
20
effective
monomers
capable
further
enhancing
tumor-killing
ability
High-throughput
transcriptomics
studies
disclosed
combination
thermotherapy
TCM
promoted
proliferation,
activation,
thereby
activating
Regulation
mitotic
cycle
exert
effects.
integration
transcriptomic
proteomic
data
demonstrated
Shengmai
Injection
significantly
enhances
by
down-regulating
Apoptosis
signaling
pathways.
Current Hematologic Malignancy Reports,
Год журнала:
2025,
Номер
20(1)
Опубликована: Янв. 4, 2025
Abstract
Purpose
of
Review
Multiple
myeloma
is
a
chronic
malignancy
and
with
evolving
treatment
options,
understanding
the
economic
burden
cost-effectiveness
therapies
crucial
for
clinicians
researchers.
Recent
Findings
In
this,
we
review
recent
approval
Bispecific
antibodies
CAR-T
their
cost
implications,
including
direct
indirect
costs.
We
compare
this
to
current
regimens
provide
comparisons
in
review.
Summary
conclude
that
use
more
effective
such
as
earlier
lines
may
be
cost-effective
depending
on
country
model
used.
Further
studies
are
essential
better
understand
bispecific
head-to-head
therapy.
Journal of Translational Genetics and Genomics,
Год журнала:
2025,
Номер
9(2), С. 62 - 75
Опубликована: Март 21, 2025
Gene
and
cell
therapies
have
emerged
as
innovative
therapeutic
strategies,
offering
a
new
paradigm
in
the
treatment
of
prostate
cancer.
This
review
explores
current
state
gene
therapies,
including
their
mechanisms,
applications,
challenges
faced
clinical
translation.
The
article
selection
was
based
on
2020
preferred
reporting
items
for
systematic
reviews
meta-analyses
(PRISMA).
Eighty-four
(84)
articles
(published
English
between
2018
2024)
from
standard
electronic
databases
were
extracted
reviewed.
Key
approaches
such
viral
vector-mediated
delivery,
CRISPR-Cas9
editing,
suicide
genes,
cell-based
like
CAR
T
therapy,
dendritic
vaccines
that
target
specific
tumor
antigens
These
promise
to
enhance
efficacy
with
few
challenges,
off-target
effects,
limited
delivery
efficiency,
immune-related
toxicities
associated
delivery.
Advances
cells,
nanoparticle-based
systems,
epigenetic
modulation
are
potential
solutions
these
challenges.
Combination
involving
immunotherapies
oncolytic
viruses
hold
synergistic
effects.
Certain
critical
regulatory,
ethical,
accessibility
issues
must
be
addressed
ensure
safe
equitable
deployment
therapies.
Continued
research
innovation
streamlined
regulatory
pathways
will
crucial
realizing
full
treating
Overcoming
fears
confronting
worldwide
might
facilitate
stream
personalized
medicine
oncology.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 27, 2025
Introduction
Following
the
approval
of
Chimeric
Antigen
Receptor
T-cell
Immunotherapy(CAR-T)
in
multiple
countries,
Food
and
Drug
Administration
(FDA)
approved
tumor-infiltrating
lymphocytes
(TILs)
receptor-engineered
T
cells
(TCR-T)
treatments
this
year.
The
utilization
adoptive
immunotherapy
tumor
treatment
has
become
increasingly
prominent.
Optimizing
cytotoxic
effects
immune
under
vitro
culture
conditions
represents
a
current
hot
research
topic
domain.
Methods
In
experiment,
we
conducted
heat
on
Jurkat-derived
at
39°C.
On
basis,
utilized
nine
distinct
injectable
solutions
over
70
monomer
components
Traditional
Chinese
Medicine
(TCM).
Subsequently,
co-cultured
these
treated
Jurkat
with
K562-eGFP
cells,
co-culture
process
was
monitored
real-time
using
IncuCyte
live-cell
analysis
system.
Equally
important,
combined
HiMAP
high-throughput
transcriptome
sequencing,
proteomics,
metabolomics
for
in-depth
examination.
We
screened
compounds
possessing
anti-tumor
properties
thoroughly
investigated
their
mechanisms
action.
Results
Discussion
findings
indicated
that
heating
augmented
effect
against
malignant
tumors,
optimal
achieved
when
were
exposed
to
39°C
duration
24
hours(48%
increase
cell
proliferation
rate
compared
37°C
treatment).
By
triggering
generation
shock
proteins
facilitating
mitochondrial
energy
supply,
amplified
functions
cells.
analyzing
data,
identified
3
more
than
20
effective
monomers
capable
further
enhancing
tumor-killing
ability
High-throughput
transcriptomics
studies
disclosed
combination
thermotherapy
TCM
promoted
proliferation,
activation,
thereby
activating
Regulation
mitotic
cycle
exert
effects.
integration
transcriptomic
proteomic
data
demonstrated
Shengmai
Injection
significantly
enhances
by
down-regulating
Apoptosis
signaling
pathways.